
Freshfields Bruckhaus Deringer announced on Thursday, March 25, that Bay Area M&A lawyer Joseph Halloum has joined the firm as a partner in its Silicon Valley office. Mr. Halloum focuses on M&A involving publicly traded companies and private equity sponsors and will help meet client demand experienced since the office launched in July 2020.
Mr. Halloum’s practice dovetails with the transactional and litigation matters that Freshfields’ Silicon Valley team is handling for Bay Area companies, including taking companies public through de-SPACs, IPOs and direct listings, defending boards of directors in litigation, and leading on governance and compensation and benefits advice. The firm’s corporate and litigation practices in Silicon Valley have been accompanied by significant demand for Freshfields’ renowned global expertise and resources in antitrust, CFIUS and foreign investment regulation, and in compliance, investigations and white-collar defense.
Notable matters handled by Mr. Halloum include the sale of Delphi Technologies to BorgWarner, the sale of Del Frisco’s to L Catterton, the sale of Smart & Final to Apollo, the Avago-Broadcom merger, The Walt Disney Company’s acquisition of Lucasfilm, Dell’s acquisition of Quest, the sale of NDS to Cisco Systems, and Vista Equity Partners in numerous software, data and technology take-private transactions, and other M&A activity.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas